Small Cell Lung Carcinoma
Showing 1 - 25 of >10,000
Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial in
Active, not recruiting
- Stage IA Non-Small Cell Lung Carcinoma
- +3 more
- Computed Tomography Perfusion Imaging
- +2 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 5, 2022
NSCLC Trial in Xinxiang (CCCR-NK92 cells)
Enrolling by invitation
- Non-small Cell Lung Cancer
- CCCR-NK92 cells
-
Xinxiang, Henan, ChinaThe first Affiliated Hospital of Xinxiang Medical University
Aug 31, 2022
Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma
Active, not recruiting
- Non Small Cell Lung Cancer
- Immune signature in serum associated to the metabolic signature
- Meta-genomic signature of intestinal flora
-
La Tronche, Isère, FranceUniversity Hospital, Grenoble
Jan 6, 2023
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy
Not yet recruiting
- Lung Cancer, Non-small Cell
- Small Cell Lung Cancer
- (no location specified)
Nov 16, 2022
Extensive Stage Small Cell Lung Carcinoma, Lung Adenocarcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in Scottsdale,
Recruiting
- Extensive Stage Small Cell Lung Carcinoma
- +7 more
- Auranofin
- +3 more
-
Scottsdale, Arizona
- +1 more
Jun 27, 2022
Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,
Active, not recruiting
- Non-Squamous Non-Small Cell Lung Carcinoma
- +7 more
- Nivolumab
- +3 more
-
Abington, Pennsylvania
- +1 more
Sep 14, 2022
EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)
Recruiting
- EGFR-Mutated Non-Small-Cell Lung Carcinoma
- Small Cell/Neuroendocrine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Non Small Cell Lung Cancer, NSCLC, Small-cell Lung Cancer Trial in Saint Louis (ADI-PEG 20, Gemcitabine, Docetaxel)
Not yet recruiting
- Non Small Cell Lung Cancer
- +3 more
- ADI-PEG 20
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 14, 2022
Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)
Recruiting
- Metastatic Non-small Cell Lung Cancer (NSCLC)
- +5 more
- data collection
-
Oldenburg, GermanyPius-Hospital
Jul 20, 2022
Proteomics in Small Cell Lung Cancer
Not yet recruiting
- Small Cell Lung Cancer
- (no location specified)
Nov 14, 2022
Observing Palliative Asymptomatic Centrally Located Advanced
Active, not recruiting
- Non-small Cell Lung Carcinoma
- None: Questionnaire Study
-
Toronto, Ontario, CanadaUniversity Health Network, Princess Margaret Hospital
Oct 6, 2022
Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Pittsburgh (Onvansertib)
Recruiting
- Small-cell Lung Cancer
- Small Cell Lung Carcinoma
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 29, 2022
Recurrent Extensive Stage Small Cell Lung Carcinoma Trial in Hangzhou, Nanjing, Zhengzhou (HTMC0435, Temozolomide)
Not yet recruiting
- Recurrent Extensive Stage Small Cell Lung Carcinoma
-
Hangzhou, China
- +2 more
Feb 5, 2023
Non-small Cell Lung Carcinoma Trial (Pembrolizumab, Paclitaxel, Carboplatin)
Completed
- Non-small Cell Lung Carcinoma
- Pembrolizumab
- +7 more
- (no location specified)
Oct 13, 2022
Participation for Small Cell Lung Cancer Patients
Not yet recruiting
- Small Cell Lung Cancer
- (no location specified)
Mar 3, 2023
Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung Trial (LB2102)
Not yet recruiting
- Small Cell Lung Cancer Extensive Stage
- Large Cell Neuroendocrine Carcinoma of the Lung
- LB2102
- (no location specified)
Jan 10, 2023
Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7, Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Trial in
Recruiting
- Stage I Non-Small Cell Lung Cancer AJCC v7
- +6 more
- Laboratory Biomarker Analysis
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 2, 2022
Small Cell Carcinoma, Hypercalcaemic Type, Ovarian Cancer Trial in Toronto (Pembrolizumab)
Active, not recruiting
- Small Cell Carcinoma, Hypercalcaemic Type
- Ovarian Cancer
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- +2 more
- AZD6244
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Immune-Connected Assays in Small Cell Lung Cancer
Recruiting
- Small Cell Lung Cancer
-
Rome, ItalyFondazione Policlinico Gemelli IRCCS
Apr 2, 2023
NSCLC Trial in Melbourne, London (Pembrolizumab, Radiotherapy (SABR))
Completed
- Non-small Cell Lung Cancer
- Pembrolizumab
- Radiotherapy (SABR)
-
Melbourne, Victoria, Australia
- +1 more
May 23, 2022
Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Saint Louis (Mycophenolate Mofetil, Allopurinol, Irinotecan)
Not yet recruiting
- Small-cell Lung Cancer
- Small Cell Lung Carcinoma
- Mycophenolate Mofetil
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
May 17, 2022
Stage I Lung Cancer, Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7 Trial in Atlanta (drug, procedure,
Active, not recruiting
- Stage I Lung Cancer
- +7 more
- Fludeoxyglucose F-18
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Mar 2, 2022
Small Cell Lung Cancer, Platinum-Sensitive Lung Small Cell Carcinoma, Extensive-stage Small-cell Lung Cancer Trial in Bordeaux
Not yet recruiting
- Small Cell Lung Cancer
- +2 more
- Association of lurbinectedin and durvalumab
- Association of carboplatin and etoposide
-
Bordeaux, FranceInstitut Bergonié
Oct 5, 2022
Small Cell Lung Cancer, Angiogenesis, Chemo Effect Trial (Surufatinib, Irinotecan)
Not yet recruiting
- Small Cell Lung Cancer
- +2 more
- (no location specified)
Nov 27, 2022